Furst, D E <br/><br/>
Updated consensus statement on biological agents, specifically tumour necrosis factor  (TNF) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.  [electronic resource] 

 -  Annals of the rheumatic diseases  Nov 2005 
 - iv2-14 p.  digital 
<br/><br/> Publication Type: Consensus Development Conference; Journal Article; Review 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.2005.044941  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Evidence-Based Medicine<br/>Humans<br/>Interleukin 1 Receptor Antagonist Protein<br/>Rheumatic Diseases--drug therapy<br/>Sialoglycoproteins--antagonists & inhibitors<br/>Spondylitis, Ankylosing--drug therapy<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors